摘要
目的探讨应用蛭龙活血通瘀胶囊治疗风痰瘀阻型急性脑梗死的临床疗效。方法将60例急性脑梗死病人,中医辨证属风痰瘀阻型,随机分为观察组30例,对照组30例。观察组采用基础治疗加蛭龙活血通瘀胶囊4粒,一日三次,对照组采用基础治疗,2周为一疗程。观察对比中医证候、中国脑卒中临床神经功能缺损评分(CSS)、美国国立卫生研究院卒中量表(NIHSS)评分、日常生活活动能力量表Barthel指数(BI)评分、实际完成日常生活活动的量表改良Rankin量表(MRS)评分。结果治疗后观察组疗效(有效率93.33%),优于对照组(有效率76.67%);治疗后两组CSS、NIHSS、BI、MRS评分均有不同程度改善,观察组CSS及BI两项评分改善较对照组显著;观察组治疗后口舌歪斜、头晕目眩、痰多而粘、舌象等症状均有改善,且观察组改善症状优于对照组。结论蛭龙活血通瘀胶囊治疗急性脑梗死疗效较为满意,能有效改善神经功能缺损评分及中医证候疗效。
Objective To study the effect of Zhilonghuoxuetongyu capsule on acute cerebral infarction with Fengtanyuzu. Methods 60 patients with acute cerebral infacction with Fengtanyuzu were randomly derided into two groups, including observe group and control group. The observe group was treated with Zhilonghuoxuetongyu capsule. The control group was treated with the basic treatment. The observation indexes included TCM syndrome contrast, the Chinese stroke clinical neurological deficit score （CSS）, the U. S. National Institutes of Health Stroke Scale （NIHSS） score, activities of daily living scale Barthel Index （BI） score and the actual completion of the activities of daily living score（Scale Modified Rankin Scale, MRS）. Results The effective rate of observe group and control group were 93. 33% and 76.67% , respectively （P〈0. 01）. CSS, NIHSS, BI and MRS score of the patients were improved after treatment, which were different between observe group and control group （P〈0. 05）. Conclusion Zhilonghuoxuetongyu capsule is effective for acute cerebral infarction.
出处
《西部医学》
2009年第11期1901-1903,共3页
Medical Journal of West China
基金
四川省中医药管理局资助项目[No.200643]
四川省科技厅2007年资助项目
关键词
蛭龙活血通瘀胶囊
急性脑梗死
缺血性中风
Zhilonghuoxuetongyu capsule
Acute cerebral infarction
Ischemic Stroke
